Supplementary Information

SUPPLEMENTARY FIGURE 3
Mouse brain hierarchy. Most elementary structures correspond to the mouse brain atlas labels. Some of these structures are very small brain regions which are not necessarily relevant in studies focusing on pathological markers. We have created a brain ontology adapted from NeuroNames ontology (http://braininfo.rprc.washington.edu) so as to merge small structures into more relevant ones. This hierarchy is made available and can be downloaded along with 3D-HAPi.
Literature survey on amyloid load quantification between 1999 and 2012. (a) Evolution over the last decade of the number of publications referenced on NCBI (http://www.ncbi.nlm.nih.gov/pubmed) that quantify Aβ deposition in mouse models of AD. (b-d) Among those publications, 51 were chosen for further analysis. Articles were selected based on journal impact factor (2012 impact factor had to be at least equal to 2) and if the quantification method was adequately described. In our publication sample, most of the scientists analyzed a total of 3 to 6 sections (b) and manually delineated 1 or 2 ROIs (c) for analysis. Once ROIs are specified, a variety of amyloid plaque segmentation methods were used (d). Some required heavy human interventions like manual segmentation/visual counting or stereology. Scientists mostly used image analysis software. Images were usually segmented using a threshold operation. Some publications did not specify the algorithm used by the software. The F1 score measures the performance of the automatic segmentation compared to ground-truth annotations. An F1 score greater than 0.7 was considered satisfactory.
SUPPLEMENTARY TABLE 3
Amyloid lowering effect of 13C3a immunotherapy in APP/PS1 mice (dataset 2). Fresh brains were snap frozen and embedded in a mixture of M1 embedding matrix (Thermo Fisher Scientific) and Fast Green (Sigma-Aldrich) before being entirely cut on a CM3050S cryostat (Leica). Four batches of serial coronal brain sections (20 μm), ranging from the brain frontal pole to the end of the caudal part of the cortex, were collected, mounted on superfrost slides and quickly dried. The first series was dedicated to Nissl staining. The fourth series was dedicated to amyloid peptide aggregate staining. The remaining series were stored at -80°C until processing. Images from the surface of the block were recorded every fourth section (before each section of the first series was cut) with a digital camera (Powershot G5 Pro, Canon) at a lateral resolution of 27 µm.
ROI
These photographs were taken at the end of the cryostat wheel crank course, hence with the brain in the same position section after section. An optic fiber-ring light was fixed onto the lens of the camera. This ensured a proper and homogeneous illumination of the sample from section to section. A laptop connected to the camera was used to remotely take photographs and store images directly onto the hard disk.
For the Nissl staining series, sections of the were stained in a solution of cresyl violet (250mg / 100ml final) prepared as follows: 1.25g of cresyl violet acetate in 500ml distilled water, filter and adjust to pH = 5 with 1N NaOH. Sections were stained with the Shandon Varistain 24-4 automate (Thermo Electron Corporation) according to the following protocol: step 01, 50 % ethanol, 1 min; step 02, 70 % ethanol, 1 min; step 03, 95 % ethanol, 1 min; step 04, 100 % ethanol, 1 min; step 05, toluene, 10 min; step 06, 100 % ethanol, 2 min; step 07, 95 % ethanol, 1 min; step 08, 70 % ethanol, 1 min; step 09, 50 % ethanol, 1 min; step 10, distilled water, 1 min; step 11, cresyl violet, 3 min, step 12, distilled water, 5 sec; step 13, 50% ethanol, 30 sec; step 14, 70% ethanol, 30 sec; step 15, 95% ethanol 40 sec; step 16, 100% ethanol, 1 min; step 17, toluene, 10 min.
To highlight Aβ peptide aggregates, after post-fixation in 4% paraformaldehyde in PBS, we performed an IHC staining with BAM10 primary monoclonal antibody (Sigma-Aldrich, 1:500 dilution), a biotinylated goat anti-mouse secondary antibody (Vector Laboratories) and staining was revealed with DAB detection kit (Ventana Medical Systems, Roche). IHC experiments were performed with the automate Discovery XT (Ventana Medical Systems, Roche). All the sections were processed identically. Sections were counter-stained with Bluing Reagent (Ventana Medical Systems, Roche).
